Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab
Crossref DOI link: https://doi.org/10.1038/cr.2016.77
Published Online: 2016-06-21
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Na, Zhenkun
Yeo, Siok Ping
Bharath, Sakshibeedu R
Bowler, Matthew W
Balıkçı, Esra
Wang, Cheng-I
Song, Haiwei
Text and Data Mining valid from 2016-06-21
Article History
First Online: 21 June 2016